A Phase 3 interventional study of Physiotherapist in Asthma and Respiratory, sponsored by P Burns. Completed. Open to participants aged 17 Years to 70 Years. Per ClinicalTrials.gov, last updated 2015-11-05.
Sponsored by P Burns · Phase 3, Interventional, and Treatment
Breathing retraining supervised by a physiotherapist will result in improvements in the quality of life and asthma control of patients treated for asthma in the community with symptoms suggestive of dysfunctional breathing.
To investigate the effects of breathing retraining on clinical and physiological parameters of asthma control, to identify the characteristics of patients who benefit, to perform a health economic evaluation.
Objectives:
3,920 studies on the registry are indexed under Asthma; 506 are open to participants now.
This study's enrollment of 182 is above the median of 83 across 2,751 interventional studies indexed under Asthma.
Browse Asthma studies →P Burns is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
equal time with health care professional (asthma nurse)
Other: Physiotherapist
Physiotherapist administered breathing retraining programme
Change in AQLQ scores between intervention and control groups in subjects with positive NQ screening scores 1 month post intervention Change in AQLQ scores between intervention groups of subjects with positive and negative NQ screening scores
Time frame: Dec 2006
Changes in bronchial hyperresponsiveness(PC 20), sputum eosinophil counts and exhaled NO between intervention and control groups in subjects with positive and negative NQ screening scores Change in ACQ Score between the intervention and the control gr
Time frame: Dec 2007
No study locations are listed for this record.
This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
P Burns